SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-034664
Filing Date
2024-04-22
Accepted
2024-04-22 08:03:33
Documents
14
Period of Report
2024-04-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0204312-8k_fresh2.htm   iXBRL 8-K 28756
2 PRESS RELEASE DATED APRIL 19, 2024 ea020431201ex99-1_fresh2.htm EX-99.1 8786
  Complete submission text file 0001213900-24-034664.txt   212540

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE fres-20240418.xsd EX-101.SCH 3006
4 XBRL LABEL FILE fres-20240418_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE fres-20240418_pre.xml EX-101.PRE 22353
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0204312-8k_fresh2_htm.xml XML 3631
Mailing Address 650 FIFTH AVENUE SUITE 2416 NEW YORK NY 10019-6108
Business Address 650 FIFTH AVENUE SUITE 2416 NEW YORK NY 10019-6108 1 917-397-6890
Fresh2 Group Ltd (Filer) CIK: 0001786511 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: 8-K | Act: 34 | File No.: 001-39137 | Film No.: 24859546
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)